High serum TNF-α level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells

Naoki Makino, Toyoki Maeda, Masahiro Sugano, Shinji Satoh, Reiko Watanabe, Nobuyuki Abe

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

A high dose of tumor necrosis factor (TNF)-α induces endothelial dysfunction and enhances apoptosis in vitro. The present study was conducted to examine whether incubating human umbilical vein endothelial cells (HUVECs) with serum from Type 2 diabetic patients complicated with retinopathy and/or microalbuminemia demonstrate endothelial dysfunction. Serum levels of TNF-α and vascular endothelial growth factor (VEGF) were elevated in diabetic patients. Plasma levels of TNF-α, two soluble TNF-α receptors (sTNFR), and VEGF were assessed in diabetic patients (CD, n=21) complicated with retinopathy and/or nephropathy, uncomplicated diabetic patients (UD, n=18), and in healthy normal participants (NS, n=16). In HUVECs incubated with patient's serum, endothelial constitutive nitric oxide synthase (eNOS) protein expressions were measured by Western blot analysis. Apoptosis in HUVECs was determined by optical microscopy, DNA fragmentation, and CPP32-like protease activity. Serum TNF-α, sTNFR-I, and asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NOS, in CD were significantly higher than in UD or NS. While, serum sTNFR-I and VEGF levels were significantly increased in the both diabetic patients, compared with those of NS, no difference was observed in the serum TNF-α, sTNFR-II, and ADMA levels between UD and NS. eNOS down-regulation and apoptosis were seen in HUVECs incubated with serum from CD for 24 h, but those observations were completely counteracted in the incubation by the addition of the antihuman TNF-α antibody. These results imply that eNOS down-regulation in CD is associated with high serum TNF-α levels despite of high serum of VEGF levels. Therefore, endothelial dysfunction in diabetic patients complicated with microangiopathy may, in part, be attributed to high serum TNF-α levels.

Original languageEnglish
Pages (from-to)347-355
Number of pages9
JournalJournal of Diabetes and Its Complications
Volume19
Issue number6
DOIs
Publication statusPublished - Nov 1 2005

Fingerprint

Nitric Oxide Synthase Type III
Down-Regulation
Endothelial Cells
Tumor Necrosis Factor-alpha
Apoptosis
Serum
Tumor Necrosis Factor Receptors
Human Umbilical Vein Endothelial Cells
Vascular Endothelial Growth Factor A
Diabetic Nephropathies
DNA Fragmentation
Microscopy
Healthy Volunteers
Peptide Hydrolases
Western Blotting
Antibodies

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

High serum TNF-α level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells. / Makino, Naoki; Maeda, Toyoki; Sugano, Masahiro; Satoh, Shinji; Watanabe, Reiko; Abe, Nobuyuki.

In: Journal of Diabetes and Its Complications, Vol. 19, No. 6, 01.11.2005, p. 347-355.

Research output: Contribution to journalArticle

@article{2e71d607f0ab440b90a7d79189847b55,
title = "High serum TNF-α level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells",
abstract = "A high dose of tumor necrosis factor (TNF)-α induces endothelial dysfunction and enhances apoptosis in vitro. The present study was conducted to examine whether incubating human umbilical vein endothelial cells (HUVECs) with serum from Type 2 diabetic patients complicated with retinopathy and/or microalbuminemia demonstrate endothelial dysfunction. Serum levels of TNF-α and vascular endothelial growth factor (VEGF) were elevated in diabetic patients. Plasma levels of TNF-α, two soluble TNF-α receptors (sTNFR), and VEGF were assessed in diabetic patients (CD, n=21) complicated with retinopathy and/or nephropathy, uncomplicated diabetic patients (UD, n=18), and in healthy normal participants (NS, n=16). In HUVECs incubated with patient's serum, endothelial constitutive nitric oxide synthase (eNOS) protein expressions were measured by Western blot analysis. Apoptosis in HUVECs was determined by optical microscopy, DNA fragmentation, and CPP32-like protease activity. Serum TNF-α, sTNFR-I, and asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NOS, in CD were significantly higher than in UD or NS. While, serum sTNFR-I and VEGF levels were significantly increased in the both diabetic patients, compared with those of NS, no difference was observed in the serum TNF-α, sTNFR-II, and ADMA levels between UD and NS. eNOS down-regulation and apoptosis were seen in HUVECs incubated with serum from CD for 24 h, but those observations were completely counteracted in the incubation by the addition of the antihuman TNF-α antibody. These results imply that eNOS down-regulation in CD is associated with high serum TNF-α levels despite of high serum of VEGF levels. Therefore, endothelial dysfunction in diabetic patients complicated with microangiopathy may, in part, be attributed to high serum TNF-α levels.",
author = "Naoki Makino and Toyoki Maeda and Masahiro Sugano and Shinji Satoh and Reiko Watanabe and Nobuyuki Abe",
year = "2005",
month = "11",
day = "1",
doi = "10.1016/j.jdiacomp.2005.04.002",
language = "English",
volume = "19",
pages = "347--355",
journal = "Journal of Diabetes and its Complications",
issn = "1056-8727",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - High serum TNF-α level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells

AU - Makino, Naoki

AU - Maeda, Toyoki

AU - Sugano, Masahiro

AU - Satoh, Shinji

AU - Watanabe, Reiko

AU - Abe, Nobuyuki

PY - 2005/11/1

Y1 - 2005/11/1

N2 - A high dose of tumor necrosis factor (TNF)-α induces endothelial dysfunction and enhances apoptosis in vitro. The present study was conducted to examine whether incubating human umbilical vein endothelial cells (HUVECs) with serum from Type 2 diabetic patients complicated with retinopathy and/or microalbuminemia demonstrate endothelial dysfunction. Serum levels of TNF-α and vascular endothelial growth factor (VEGF) were elevated in diabetic patients. Plasma levels of TNF-α, two soluble TNF-α receptors (sTNFR), and VEGF were assessed in diabetic patients (CD, n=21) complicated with retinopathy and/or nephropathy, uncomplicated diabetic patients (UD, n=18), and in healthy normal participants (NS, n=16). In HUVECs incubated with patient's serum, endothelial constitutive nitric oxide synthase (eNOS) protein expressions were measured by Western blot analysis. Apoptosis in HUVECs was determined by optical microscopy, DNA fragmentation, and CPP32-like protease activity. Serum TNF-α, sTNFR-I, and asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NOS, in CD were significantly higher than in UD or NS. While, serum sTNFR-I and VEGF levels were significantly increased in the both diabetic patients, compared with those of NS, no difference was observed in the serum TNF-α, sTNFR-II, and ADMA levels between UD and NS. eNOS down-regulation and apoptosis were seen in HUVECs incubated with serum from CD for 24 h, but those observations were completely counteracted in the incubation by the addition of the antihuman TNF-α antibody. These results imply that eNOS down-regulation in CD is associated with high serum TNF-α levels despite of high serum of VEGF levels. Therefore, endothelial dysfunction in diabetic patients complicated with microangiopathy may, in part, be attributed to high serum TNF-α levels.

AB - A high dose of tumor necrosis factor (TNF)-α induces endothelial dysfunction and enhances apoptosis in vitro. The present study was conducted to examine whether incubating human umbilical vein endothelial cells (HUVECs) with serum from Type 2 diabetic patients complicated with retinopathy and/or microalbuminemia demonstrate endothelial dysfunction. Serum levels of TNF-α and vascular endothelial growth factor (VEGF) were elevated in diabetic patients. Plasma levels of TNF-α, two soluble TNF-α receptors (sTNFR), and VEGF were assessed in diabetic patients (CD, n=21) complicated with retinopathy and/or nephropathy, uncomplicated diabetic patients (UD, n=18), and in healthy normal participants (NS, n=16). In HUVECs incubated with patient's serum, endothelial constitutive nitric oxide synthase (eNOS) protein expressions were measured by Western blot analysis. Apoptosis in HUVECs was determined by optical microscopy, DNA fragmentation, and CPP32-like protease activity. Serum TNF-α, sTNFR-I, and asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NOS, in CD were significantly higher than in UD or NS. While, serum sTNFR-I and VEGF levels were significantly increased in the both diabetic patients, compared with those of NS, no difference was observed in the serum TNF-α, sTNFR-II, and ADMA levels between UD and NS. eNOS down-regulation and apoptosis were seen in HUVECs incubated with serum from CD for 24 h, but those observations were completely counteracted in the incubation by the addition of the antihuman TNF-α antibody. These results imply that eNOS down-regulation in CD is associated with high serum TNF-α levels despite of high serum of VEGF levels. Therefore, endothelial dysfunction in diabetic patients complicated with microangiopathy may, in part, be attributed to high serum TNF-α levels.

UR - http://www.scopus.com/inward/record.url?scp=27644547762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644547762&partnerID=8YFLogxK

U2 - 10.1016/j.jdiacomp.2005.04.002

DO - 10.1016/j.jdiacomp.2005.04.002

M3 - Article

VL - 19

SP - 347

EP - 355

JO - Journal of Diabetes and its Complications

JF - Journal of Diabetes and its Complications

SN - 1056-8727

IS - 6

ER -